TE_20420
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MER61A |
|---|---|
| TE superfamily | ERV1 |
| TE class | LTR |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 543.82 |
| Counts of samples | TCGA_tumor:964; TCGA_normal:0; GTEx:1 |
| TSS | chr9(+):31848660 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_20420.21 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31942991,31943204,31973015,31973112,31977495,31977597,32062375,32062489,32085354,32085376,32087312,32087332 |
| teRNA_20420.22 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31942991,31943204,31973015,31973112,32062375,32062489,32085354,32085376,32087312,32087332 |
| teRNA_20420.23 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31942991,31943204,31973015,31973112,32020882,32020902 |
| teRNA_20420.24 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31942991,31943204,31973015,31973112,32062375,32062489,32085354,32085376,32112170,32112190 |
| teRNA_20420.25 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31948713,31948733 |
| teRNA_20420.26 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31948713,31948876,31959038,31959058 |
| teRNA_20420.27 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31910820,31910840 |
| teRNA_20420.28 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31853521,31853541 |
| teRNA_20420.29 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31885643,31885663 |
| teRNA_20420.30 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31885643,31885680,31942991,31943011 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
